dc.contributorBeck, Sandra Trevisan
dc.creatorCaetano, Miriam Maria
dc.date.accessioned2015-08-19T14:09:02Z
dc.date.accessioned2019-05-24T21:13:14Z
dc.date.available2015-08-19T14:09:02Z
dc.date.available2019-05-24T21:13:14Z
dc.date.created2015-08-19T14:09:02Z
dc.date.issued2005
dc.identifierhttp://repositorio.ufsm.br/handle/1/953
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2846512
dc.description.abstractBackground: The global prevalence of hepatitis B virus (HBV) is estimated to be 350 million of chronic carriers. In Brazil this prevalence is about eight percent (8%), with regional variations. One of the greatest risks for the transmission of this infection is blood transfusions and blood derivates. To prevent the post-transfusion hepatitis B, the markers HBsAg, the antibody Anti-HBc, and the transaminase ALT are determined, and show the presence of different serological profiles among the blood donators. Objectives: Determine the presence of isolated anti-Hbc in present population. Material and Method: data from the blood transfusion center in Santiago/RS, Brazil, was analyzed in the year of 2004. Results: it has been estimated the prevalence of 1.9 % for HBV infection, with 1.59 % of these individuals reagents only to the anti-HBc . Discussion: The existence of this serological profile has been discussed considering the possibility of undetectable low levels of HBsAg or the presence of mutant strains. Conclusions: in front of this possibility we believe that is important to continue determining the anti-HBc marker in the serological blood donor screening.
dc.publisherUniversidade Federal de Santa Maria
dc.publisherCentro de Ciências da Saúde
dc.rightsAcesso Aberto
dc.subjectHepatite B
dc.subjectHBsAg
dc.subjectAnti-HBc
dc.subjectTransfusão
dc.titleImportância da detecção de anticorpos ANTI-HBc na prevenção da transmissão do vírus da hepatite B (VHB) em bancos de sangue
dc.typeTrabalho de Conclusão de Curso de Especialização


Este ítem pertenece a la siguiente institución